表紙
市場調查報告書

輸血設備的全球市場:成長率、趨勢、預測

Global Blood Transfusion Device Market - Growth, Trends, and Forecasts (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 567972
出版日期 內容資訊 英文 125 Pages
商品交期: 2-3個工作天內
價格
輸血設備的全球市場:成長率、趨勢、預測 Global Blood Transfusion Device Market - Growth, Trends, and Forecasts (2017 - 2022)
出版日期: 2017年09月01日內容資訊: 英文 125 Pages
簡介

本報告提供全球輸血用各種設備的市場相關分析,產品概要和市場基本結構,主要的推動及市場的阻礙要素,市場規模趨勢預測 (今後6年份),各產品、各終端用戶、各地區的詳細趨勢,市場競爭的動向,主要企業簡介,今後的市場方向性等調查。

第1章 簡介

  • 市場定義

第2章 分析方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析

第6章 市場的推動因素與阻礙因素、機會、課題分析 (DROC分析)

  • 市場的推動要素
  • 市場的阻礙要素
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品的明細
    • 血液採取設備 (血袋,冷藏設備等)
    • 血液處理設備 (過濾設備,成分分離設備等)
    • 血液保護設備 (病原體消除設備)
    • 消耗品
    • 其他
  • 各終端用戶的明細
    • 醫院
    • 血庫 (血液中心)
    • 實驗室
    • 血漿分餾設施
    • 其他
  • 各地區的明細
    • 北美 (美國,加拿大,墨西哥)
    • 歐洲 (法國,德國,英國,義大利,西班牙等)
    • 亞太地區 (中國,日本,印度,澳洲、紐西蘭,韓國等)
    • 中東、非洲 (波灣合作理事會 (GCC) 各國,南非等)
    • 南美 (巴西,阿根廷等)

第8章 競爭環境

  • 企業合併、收購 (M&A) 分析
  • 協定,產業合作、聯盟
  • 新產品的銷售

第9章 主要企業

  • Macopharma
  • Becton Dickinson
  • B.Braun
  • Terumo Corporation
  • Haemonetics
  • Fresenius Kabi
  • Immucor
  • Fenwal
  • Abbott
  • 其他

第10章 市場未來展望

目錄

The global blood transfusion device market was valued at USD XX million in 2016. Considering the historical trend and possible future developments, the market is projected to reach USD XX million by 2022, with a CAGR of XX% over 2017-2022 (the forecast period).

Blood transfusion is a process of infusing the whole blood or blood components into systemic circulation intravenously. The report focuses on the market for medical devices and consumables employed for blood collection, processing, safety analyses, and storage during the transfusion process.

Drivers:

The market is mainly driven by increase in complex surgical procedures like heart and orthopedic surgeries. Increasing transfusion safety and rise in R&D initiatives in the field of regenerative medicine are contributing to the market expansion.

Restraints:

Stringent rules and regulations like approvals needed for separation of blood components limit the total number of end-users, thereby, reducing the market size.

Market Segmentation:

The global blood transfusion device market has been segmented based on product type (blood collection, blood processing, blood safety, consumable & supplies, and others), by the end-user (hospital, blood bank, laboratory, plasma fractionation facility, and others) and by region (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)

The report provides a detailed overview of each type of blood transfusion device, along with an in-depth analysis, in addition to company profiles of major players in the space and a clear picture of a competitive landscape that currently exists in the market.

Some of the key players in the global blood transfusion device market include -

Macopharma, Becton Dickinson, B.Braun, Terumo, Haemonetics, Fresenius Kabi, Immucor, Fenwal, Abbott, etc.

Key Deliverables:

  • Market analysis for the global blood transfusion device market, with region-specific assessments and competition analysis.
  • Market definition, along with the identification of key drivers, restraints, opportunities, and challenges.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section and company profiles of key players, with analysis of the current strategic interests and key financial information.
  • Identification and analysis of the macro and micro factors that affect the global blood transfusion device market.
  • Insights of the market in the regions that have the highest potential for growth and identification of untapped markets.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Products and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Increasing Transfusion Safety
    • 6.1.2 Rise in Complex Surgical Procedures
    • 6.1.3 Increase in R&D Initiatives for Regenerative Medicine
  • 6.2 Market Restraints
    • 6.2.1 High Costs Associated with Handling of Blood and its Components
    • 6.2.2 Strict Approval Process and Regulations
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 Segmentation-By Product
    • 7.1.1 Blood Collection
      • 7.1.1.1 Blood Bag and Accessory
      • 7.1.1.2 Blood Mixer
      • 7.1.1.3 Sealer
      • 7.1.1.4 Fridge and Freezer
    • 7.1.2 Blood Processing
      • 7.1.2.1 Filter
      • 7.1.2.1.1 Inline Filter
      • 7.1.2.1.2 Dockable Filter
      • 7.1.2.2 Additive Solution
      • 7.1.2.3 Blood Component Separator
      • 7.1.2.4 Apheresis Device
    • 7.1.3 Blood Safety
      • 7.1.3.1 Pathogen Reduction System
      • 7.1.3.1.1 For Plasma
      • 7.1.3.1.2 For Platelet
      • 7.1.3.1.3 For RBC Concentrate
    • 7.1.4 Consumables and Supplies
    • 7.1.5 Others
  • 7.2 Segmentation-By End-user
    • 7.2.1 Hospital
    • 7.2.2 Blood Bank
    • 7.2.3 Laboratory
    • 7.2.4 Plasma Fractionation Facility
    • 7.2.5 Others
  • 7.3 Segmentation-By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States
      • 7.3.1.2 Canada
      • 7.3.1.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 France
      • 7.3.2.2 Germany
      • 7.3.2.3 United Kingdom
      • 7.3.2.4 Italy
      • 7.3.2.5 Spain
      • 7.3.2.6 Rest Of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China
      • 7.3.3.2 Japan
      • 7.3.3.3 India
      • 7.3.3.4 Australia & New Zealand
      • 7.3.3.5 South Korea
      • 7.3.3.6 Rest Of Asia-Pacific
    • 7.3.4 Middle East And Africa
      • 7.3.4.1 GCC
      • 7.3.4.2 South Africa
      • 7.3.4.3 Rest Of Middle East And Africa
    • 7.3.5 South America
      • 7.3.5.1 Brazil
      • 7.3.5.2 Argentina
      • 7.3.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers and Acquisitions Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Product Launches

9. Key Players

  • 9.1 Macopharma
  • 9.2 Becton Dickinson
  • 9.3 B.Braun
  • 9.4 Terumo
  • 9.5 Haemonetics
  • 9.6 Fresenius Kabi
  • 9.7 Immucor
  • 9.8 Fenwal
  • 9.9 Abbott
  • 9.10 Others

10. Future of the Market